Literature DB >> 11131542

Neural stem cells are uniquely suited for cell replacement and gene therapy in the CNS.

V Ourednik1, J Ourednik, K I Park, Y D Teng, K A Aboody, K I Auguste, R M Taylor, B A Tate, E Y Snyder.   

Abstract

In recent years, it has become evident that the developing and even the adult mammalian CNS contain a population of undifferentiated, multipotent cell precursors, neural stem cells, the plastic properties of which might be of advantage for the design of more effective therapies for many neurological diseases. This article reviews the recent progress in establishing rodent and human clonal neural stem cell lines, their biological properties, and how these cells can be utilized to correct a variety of defects, with prospects for the near future to harness their behaviour for neural stem cell-based treatment of diseases in humans.

Entities:  

Mesh:

Year:  2000        PMID: 11131542     DOI: 10.1002/0470870834.ch15

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  8 in total

Review 1.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  Generation of neural stem cell-like cells from bone marrow-derived human mesenchymal stem cells.

Authors:  K Ma; L Fox; G Shi; J Shen; Q Liu; J D Pappas; J Cheng; T Qu
Journal:  Neurol Res       Date:  2011-12       Impact factor: 2.448

3.  Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.

Authors:  M A Tyler; I V Ulasov; A M Sonabend; S Nandi; Y Han; S Marler; J Roth; M S Lesniak
Journal:  Gene Ther       Date:  2008-12-11       Impact factor: 5.250

Review 4.  Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.

Authors:  Diana Yu; Gabriel A Silva
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

5.  A rat model for studying neural stem cell transplantation.

Authors:  Xue-mei Zhou; Jing-bo Sun; Hui-ping Yuan; Dong-lai Wu; Xin-rong Zhou; Da-wei Sun; Hong-yi Li; Zheng-bo Shao; Zhi-ren Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

6.  Repair of glutamate-induced excitotoxic neuronal damage mediated by intracerebroventricular transplantation of neural stem cells in adult mice.

Authors:  Juan Ma; Li-Jian Yu; Run-Di Ma; Yong-Ping Zhang; Juan-Zhi Fang; Xiao-Yu Zhang; Ting-Xi Yu
Journal:  Neurosci Bull       Date:  2007-07       Impact factor: 5.203

7.  Development of a tumor-selective approach to treat metastatic cancer.

Authors:  Karen S Aboody; Rebecca A Bush; Elizabeth Garcia; Marianne Z Metz; Joseph Najbauer; Kristine A Justus; Doris A Phelps; Joanna S Remack; Karina Jin Yoon; Shanna Gillespie; Seung U Kim; Carlotta A Glackin; Philip M Potter; Mary K Danks
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

8.  AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study.

Authors:  Ali M Rad; A S M Iskander; Branislava Janic; Robert A Knight; Ali S Arbab; Hamid Soltanian-Zadeh
Journal:  BMC Biotechnol       Date:  2009-03-27       Impact factor: 2.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.